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a  b  s  t  r  a  c  t
As  Chinese  Hamster  Ovary  (CHO)  cells  are  the  cell  line  of choice  for the  production  of human-like  recom-
binant  proteins,  there  is interest  in  genetic  optimization  of host  cell lines  to overcome  certain  limitations
in  their  growth  rate and  protein  secretion.  At the same  time,  a detailed  understanding  of  these  processes
could  be  used  to advantage  by identiﬁcation  of  marker  transcripts  that  characterize  states  of  performance.
In this  context,  microRNAs  (miRNAs)  that  exhibit  a robust  correlation  to the growth  rate  of  CHO  cells
were  determined  by  analyzing  miRNA  expression  proﬁles  in  a comprehensive  collection  of  46 samples
including  CHO-K1,  CHO-S  and CHO-DUKXB11,  which  were  adapted  to various  culture  conditions,  and
analyzed  in  different  growth  stages  using  microarrays.  By  applying  Spearman  or  Pearson  correlation
coefﬁcient  criteria  of  > |0.6|,  miRNAs  with  high  correlation  to the  overall  growth,  or growth  rates  observedrowth
orrelation
in  exponential,  serum-free,  and  serum-free  exponential  phase  were  identiﬁed.  An  overlap  of twelve
miRNAs  common  for all sample  sets  was  revealed,  with  nine  positively  and  three  negatively  correlating
miRNAs.
The here  identiﬁed  panel  of  miRNAs  can  help  to  understand  growth  regulation  in  CHO  cells and  contains
putative  engineering  targets  as  well  as biomarkers  for cell  lines  with  advantageous  growth  characteristics.
© 2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Chinese Hamster Ovary (CHO) cell lines are the most frequently
sed mammalian cell factory for the production of therapeutic pro-
eins (Walsh, 2014). Enhancement of the phenotype of these cells
owards faster growth, higher productivity, better product qual-
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/).ity and increased robustness is the major goal in bioprocess and
cell line engineering and therefore highly desired. Media optimiza-
tion (Kishishita et al., 2015; Xu et al., 2014), process improvement
(Trummer et al., 2006; Lu et al., 2013) and genetic engineering were
used to achieve the above mentioned objectives. The latter was
mostly conducted by directly altering gene expression of a small
number of protein-coding genes, known to be related to a certain
pathway (Jeon et al., 2011; Lee et al., 2013). More recently, addi-
tional engineering candidates were revealed by different “-omics”
technologies (Lin et al., 2015; Courtes et al., 2013).
Another promising genetic engineering approach of CHO cells,
which is based on post-transcriptional regulation by miRNAs,
gained interest in the last years (Jadhav et al., 2013). The advantages
of those short (21–24 nucleotides), non-coding RNAs (Finnegan
and Pasquinelli, 2012) are that one miRNA can target hundreds of
genes without burdening the translational machinery (Hackl et al.,
2012a). MicroRNAs are encoded in intergenic and intronic regions,
































































0-SF-PROD-M17 additionally harbors a vector overexpressing
miR-17, while DUKXB11-FERM-0-SF-PROD-MNC harbors anG. Klanert et al. / Journal of B
nd are often located in close chromosomal proximity (Altuvia
t al., 2005). According to miRBase version 21 (v21) (Kozomara and
rifﬁths-Jones, 2014), 31% of Mus  musculus, 25% of Homo sapiens,
nd 54% of Rattus norvegicus annotated miRNAs are found in an
nter-miRNA distance below 10 kilobases (kb), and are considered
o be clustered. Individual or cooperative transcription, occurring
or clustered miRNAs (Baskerville and Bartel, 2005), forms a long,
rimary transcript (pri-miRNA), which is processed in the nucleus
y the microprocessor complex to release a stem-loop with a length
f ∼65 nucleotides, called precursor miRNA (pre-miRNA or mir)
Lee et al., 2003). After export into the cytoplasm by Exportin-
 (Yi et al., 2003), the stem-loop is recognized and processed by
icer (Hutvágner et al., 2001) to produce a RNA duplex, consisting
f the 5p and the 3p mature microRNA (miR) strands. While one
s preferentially incorporated into the miRISC (microRNA-loaded
NA-induced silencing complex) (Bergauer et al., 2009), the other
trand is usually, but not always, degraded (Krol et al., 2010). The
iRISC recognizes target mRNAs, which bear mostly imperfect
omplementary regions in the three prime untranslated region (3′
TR) to the miRNA, guiding translational repression (Zeng et al.,
002) or mRNA cleavage (Zeng et al., 2003).
Identiﬁcation (Gammell et al., 2007; Kantardjieff et al., 2009;
ohnson et al., 2011; Hackl et al., 2011), localization (Hackl
t al., 2012b) and expansion (Diendorfer et al., 2015) of the CHO
iRNome and method development (Jadhav et al., 2012; Fischer
t al., 2013; Klanert et al., 2014) to alter miRNA expression have
rovided a sound basis for miRNA research and application in CHO
ells. Several miRNAs were reported to drive CHO cells to desired
henotypes. These so-called engimiRs were able to enhance pro-
uctivity (Barron et al., 2011; Sanchez et al., 2014; Strotbek et al.,
013; Loh et al., 2014; Fischer et al., 2014; Jadhav et al., 2014;
elly et al., 2015), growth (Jadhav et al., 2012; Sanchez et al., 2014)
r increase apoptosis-resistance (Druz et al., 2011, 2013). MiR-
As for engineering were selected the same way as protein-coding
enes, based on previously published literature, ‘omics’-studies or
igh-throughput screenings. The latter is able to test the effect
f the whole miRNome and identiﬁes all miRNAs related to the
henotypes observed (Strotbek et al., 2013; Fischer et al., 2014,
015). Since the method is very cost- and labor-intense, normally
nly one cell line in one condition is tested, and the best candi-
ates are selected for further testing in other cell lines. Proﬁling of
HO miRNA expression using either next-generation sequencing
Hackl et al., 2011; Johnson et al., 2011; Hammond et al., 2012; Loh
t al., 2014) or arrays (Gammell et al., 2007; Barron et al., 2011;
in et al., 2011; Druz et al., 2011; Bort et al., 2012; Clarke et al.,
012; Maccani et al., 2014; Hackl et al., 2014) revealed differen-
ially expressed miRNAs for speciﬁc conditions and phenotypes,
ut the conducted studies were often focused on a small set of cell
ines.
Here we present the results from a comprehensive approach
o identify growth associated miRNAs by proﬁling miRNA expres-
ion in CHO-K1, CHO-DUKXB11 and CHO-S cell lines, among them
erum, serum-free, and l-Glutamine (l-Gln)-free adapted host,
ecombinant and engineered cells, grown in different cultiva-
ion systems. MiRNA expression was characterized in different
rowth phases by microarray analysis. This comprehensive set of
iRNA expression data allowed us to identify growth-correlating
iRNAs valid for a wide variety of different CHO cell lines
nd culture conditions. These miRNAs will be good candidates
o test for their potential as engimiRs, to favorably alter cell
rowth in biotechnological processes, but also as ‘diagnostic’
ools to identify cell lines and clones with high growth potential
nd to indicate changes in growth during process develop-
ent.nology 235 (2016) 150–161 151
2. Material and methods
2.1. Sample ID generation
Sample IDs were generated, based upon following structure:
[cell line]-[cultivation method]-[l-Gln supplementation]-
[serum supplementation]-[host/producer]-[engineered
(optional)]-[biological replicate (optional)]-[RNA sampling
timepoint]-[technical replicate]-[array-number]. The [cell line]
represents either the CHO-K1 (K1), CHO-S (S), or the CHO-
DUKXB11 (DUKXB11) cell line, whereas the [cultivation method]
implies whether cells were cultivated statically for adherent (ADH)
growth, or either shaken (SHAKE) or in a fermenter (FERM) for
suspension cultures. The [l-Gln supplementation] depicts the
amount of l-glutamine (0/4/8) in mM added, and the [serum
supplementation] indicates whether cells were cultivated in the
presence of 5% fetal calf serum (FCS) or serum-free (SF). The
[host/producer] points out whether the cells function as host
cell line (HOST) or produce an Erythropoietin-Fc fusion protein
(PROD). The [engineered (optional)] is only depicted at sam-
ples which harbor a vector overexpressing miR-17 (M17) or an
empty vector control (MNC). For Fig. 1 and Supplementary Table
1, [biological replicate] indicates the biological replicate by an
additional number (1–4), if more than one biological replicate was
conducted, and also the timepoint of RNA sampling (D1-D9) is
included via [RNA sampling timepoint]. In addition, Fig. 1B also
contains [technical replicate], depicting the technical replicate (R1
or R2) used for hybridization. Also, in Fig. 1B, if more than one
microarray was  performed per technical replicate, it is indicated
via [array-number] by an additional number (1–3).
2.2. Cell culture
All CHO cell lines were cultivated at 37 ◦C, 7% CO2 and humid-
iﬁed atmosphere. K1-STAT-4-FCS-HOST (CHO-K1, ECACC-CCL61)
and DUKXB11-STAT-4-FCS-HOST (CHO-DUKXB11, ATCC CRL-9096)
were grown in DMEM/Ham’s F12 media (1:1, Merck KGaA, Darm-
stadt, Germany) supplied with 5% fetal calf serum (GE Healthcare,
Little Chalfont, UK) and 4 mM l-Gln. DUKXB11-STAT-4-FCS-HOST
cells were additionally supplied with 1x hypoxanthine/thymidine
(HT) supplement (Thermo Fisher Scientiﬁc, Waltham, MA).
DUKXB11-SHAKE-4-SF-HOST (suspension and serum-
free adapted CHO-DUKXB11) cells were cultivated in
DMEM/Ham’s F12 (1:1), supplemented with 4 mM l-Gln,
0.25% soy peptone, 0.1% Pluronic F68 (BASF, Germany),
1x protein free supplement (Polymun Scientiﬁc, Austria)
and 1x HT supplement. K1-SHAKE-8-SF-HOST/K1-FERM-
8-SF-HOST (suspension and serum-free adapted CHO-K1),
K1-SHAKE-0-SF-HOST/K1-FERM-0-SF-HOST (suspension, serum-
free and l-Gln-free adapted CHO-K1), S-SHAKE-8-SF-HOST
(CHO-S), DUKXB11-SHAKE-0-SF-PROD/DUKXB11-FERM-0-SF-
PROD-M17/DUKXB11-0-SF-FERM-PROD-MNC (recombinant
suspension and serum-free adapted CHO-DUKXB11, producing an
Erythropoietin-Fc fusion protein) were grown in CD CHO (Thermo
Fisher Scientiﬁc), supplemented with 1x Anti-Clumping Agent
(Thermo Fisher Scientiﬁc). K1-SHAKE-8-SF-HOST/K1-FERM-8-
SF-HOST and S-SHAKE-8-SF-HOST were additionally supplied
with 8 mM  l-Gln. DUKXB11-SHAKE-0-SF-PROD, DUKXB11-FERM-
0-SF-PROD-M17 and DUKXB11-0-SF-FERM-PROD-MNC cells
were supplied with 0.19 M methotrexate. DUKXB11-FERM-empty vector control. DUKXB11-SHAKE-4-SF-HOST, K1-SHAKE-
8-SF-HOST, K1-SHAKE-0-SF-HOST, S-SHAKE-8-SF-HOST and
152 G. Klanert et al. / Journal of Biotechnology 235 (2016) 150–161
Fig. 1. Sample characteristics. (A) Growth rates of all CHO cell lines analyzed in this study at the time of RNA sampling. (B) Unsupervised sample clustering based on miRNA
expression patterns. Red: Samples drawn from the fermenter in stationary/decline phase. Blue: Samples drawn from the fermenter in exponential phase. (For interpretation
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UKXB11-SHAKE-0-SF-PROD were cultivated in shaker ﬂasks at
40 revolutions per minute (rpm) and a 25 mm shaking diameter.
K1-FERM-8-SF-HOST, K1-FERM-0-SF-HOST, DUKXB11-FERM-
-SF-PROD-M17 and DUKXB11-FERM-0-SF-PROD-MNC were cul-
ivated in DASGIP bioreactor system (DASGIP AG, Jülich, Germany)
ontrolled by DASGIP Control 4.0 software with similar settings as
escribed before (Taschwer et al., 2012). Brieﬂy, advanced spin-
er vessels with 800 ml  working volume, magnetic drive and
itch blade impellers for constant stirring (80 rpm) were used for
he cultivation. Temperature was maintained at 37 ◦C, constant
0% oxygen concentration was held via probe (Broadley James
xyprobe) by air saturation and neutral pH (Mettler Toledo) was
egulated with 0.5 M NaOH and CO2.
.3. RNA isolation
RNA was extracted using the phenol-chloroform extraction
ethod. Adherent CHO cell lines were washed with PBS and
etached using Trypsin. Adherent and suspension cells were
ollected by centrifugation and lysed using TRI reagent (Sigma-
ldrich, St. Louis, MO). RNA isolation was performed according to
he manufacturer’s recommendations. In brief, phase separation
as conducted by the addition of chloroform, and the aqueous
hase was collected. After precipitation by 2-Propanol addition and
ashing with 70% Ethanol, RNA pellets were air-dried, and resus-
ended in nuclease-free water (NFW).
.4. RNA quality and quantity assessment
For quantity and purity estimation, absorbances at 230, 260
nd 280 nm were measured using a NanoDrop ND-1000 UV–vis
pectrophotometer (Thermo Fisher Scientiﬁc). Total RNA quality
as assessed on the 2100 Bioanalyzer (Agilent Technologies, Santa
lara, CA) using the RNA 6000 Nano Kit (Agilent Technologies). Only
NA samples with a RNA integrity number (RIN) > 7 were used for
icroarray hybridization.
.5. MicroRNA microarray hybridization
Cross-species microRNA microarrays were generated as
escribed previously (Bort et al., 2012) by spotting a locked nucleic
cid (LNA) probe set on epoxy-coated Nexterion glass slides. The
robe set consisted of 8 replicates per slide, each targeting 2367
uman, mouse, rat and viral miRNAs of miRBase v16. All sam-
les, consisting of 800 ng total RNA extracts, were blended with
he Spike-in miRNA kit v2 (Exiqon, Denmark) and labelled with
y3 by the miRCURY LNA microRNA Hi-Power labeling Kit (Exiqon)
ccording to the manufacturer’s protocol. A common reference
ool (CRP) was processed equally, but labelled with Hy5. Sam-
les were then pooled with the CRP, heat-denaturated for 2 min
t 95 ◦C, and hybridized onto the microarrays mentioned above
t 56 ◦C for 16 h using the TECAN HS 400 hybridization station
Tecan, Switzerland). Immediately after washing and drying, the
rray slides were scanned at 532 and 635 nm wavelengths at
0 m resolution using a Roche Nimblegen MS200 scanner (Roche,
witzerland) and auto-gain settings.
.6. Data processing
Feature extraction from the generated images was performed
sing GenePix 4.1 (Molecular Devices, Sunnyvale, CA). The result-
ng GPR-ﬁles were processed in R/Bioconductor (R Core Team,
015) using the LIMMA  package (Ritchie et al., 2015). Raw data
f previously published arrays (Hackl et al., 2014) (Gene Expres-
ion Omnibus accession number: GSE52994) was compiled withnology 235 (2016) 150–161 153
the here generated data for jointly analysis. Global LOESS normal-
ization and Normexp background correction were performed, and
the log2-fold changes of the miRNAs were calculated against the
common reference pool (LogFC) for each array. To be considered
expressed, the average probe intensity had to exceed the aver-
age background intensity plus two times the standard deviation.
The probe’s validity was  reviewed by updating the correspond-
ing miRNA accessions to miRBase v21. The compiled data has been
submitted to Gene Expression Omnibus (http://www.ncbi.nlm.nih.
gov/geo/) and can freely be downloaded and reanalyzed using the
accession number GSE75830.
2.7. Growth rate determination
Culture’s viable cell densities were determined by the ViCell
(Beckman Coulter, Brea, CA), which uses the trypan blue exclusion
method. One time point before, the time point of RNA isolation and
the time point after isolation were linearly correlated with their
respective ln-transformed viable cell densities to retrieve the slope
of the function, which corresponds to the growth rate at RNA sam-
pling, and the coefﬁcient of determination. If existent, technical
replicates were combined.
2.8. Probe mapping
Consensus sequences of all microRNAs assigned to a microarray
probe were retrieved from miRBase v16 and mapped to annotated
microRNA stem-loop sequences of Cricetulus griseus (C. griseus) of
miRBase v21 and to additionally identiﬁed microRNA stem-loop
sequences present in the four genome assemblies of CHO and C.
griseus (Diendorfer et al., 2015).
2.9. Clustering
Based on the LogFC values, euclidean distance matrices were
calculated and dendrograms were generated in R for all samples
and for all valid microRNA probes above background.
2.10. Growth rate correlation
All valid probes above the background were correlated to the
growth rates of all arrays, all serum-free samples (SF), all expo-
nential samples (samples taken before day 6), or all exponential
and serum-free samples (SF-samples taken before day 6). A Pearson
correlation coefﬁcient or a Spearman correlation coefﬁcient > |0.6|
was set as cutoff. Furthermore, a (LogFC) > |1| between all samples
was set as an additional criteria.
3. Results
3.1. Growth and miRNA proﬁling of diverse CHO  cells
Growth proﬁles of different CHO cell cultures were collected,
including adherent and suspension-adapted host and producer cell
lines, cultivated under different conditions. A total of 46 miRNA
proﬁles were generated from 31 biological samples by microarrays,
and growth rates were calculated, ranging from −0.34 to 1.18 d−1
(see Fig. 1A and Supplementary Table 1). MicroRNA microarrays
based on miRBase v16 were hybridized using a common refer-
ence design, and the resulting raw data were normalized. Log2 fold
changes against the common reference pool (LogFC) and average
expression values (AvExp) were retrieved for all miRNA probes. Out
of 2367 probes, 295 showed a signal intensity (AvExp) above back-
ground criteria (see Supplementary Table 2). The annotated miRNA
IDs for these probes were updated from miRBase v16 to miRBase


























































t54 G. Klanert et al. / Journal of B
iRBase v21, some of the probe IDs (n = 18) had been disproved as
ature miRNAs in miRBase v21 and were excluded from further
nalyses. Around 46% (n = 128) of the probe sequences perfectly
atched to already annotated stem-loop sequences.
.2. Sample clustering indicates factors inﬂuencing global miRNA
xpression
Unsupervised clustering was performed using the expres-
ion values (LogFC) of all 277 expressed miRNAs in 46 samples.
he Dendrogram (see Fig. 1B) was visually inspected to iden-
ify factors inﬂuencing overall miRNA expression. It was observed
hat all but one sample (DUKXB11-FERM-0-SF-PROD-MNC-D7)
aken in stationary/death-phase cluster together, and all samples
rawn from the fermenter in exponential phase (. . .-FERM-.  . .-
1/D3/D4/D5) also cluster together. All samples of the producer
ell line (DUKXB11-. . .-PROD-.  . .)  taken in exponential phase clus-
er together despite different cultivation methods, and share
iRNA expression patterns with the serum-free and suspension-
dapted host cell line (DUKXB11-SHAKE-4-SF-HOST-D2). The
iRNA expression patterns of the other cell lines vary more widely,
s individual samples of the same cell lines do not clearly cluster
ogether.
.3. Growth correlation indicates that speciﬁc miRNA expression
s associated with the growth rate
In order to identify growth-correlating miRNAs, the LogFC of the
iRNAs were correlated to the growth rate measured for all sam-
les. A Pearson and a Spearman correlation were applied, and all
iRNAs exceeding a correlation coefﬁcient of |0.6| in at least one
f those two correlations were considered as growth-correlating
iRNAs. Further, to only include miRNAs for which the expres-
ion also changes upon growth variation, a (LogFC) > |1| between
ll samples was set as criteria (the range of observed logFC values
ad to exceed 1 log-value). When all 46 arrays were considered,
3 miRNAs fulﬁlled the above mentioned criteria. Growth correla-
ions for sample subsets identiﬁed 48 growth-correlating miRNAs
or the serum-free samples (all sample IDs without FCS), 25 cor-
elating miRNAs for the exponential (all sample IDs up to day 5),
nd 30 correlating miRNAs for serum-free exponential samples (all
ample IDs without FCS up to day 5, see Fig. 2A and Supplementary
able 3). The majority of miRNAs fulﬁlling the criteria were posi-
ively correlated to the growth rate (∼72–83%). Each data set bears
 separate amount of identiﬁed miRNAs (n = 9–13, see Fig. 2B), but
n overlap between all sample sets, consisting of 12 miRNAs (see
able 1) and another overlap between all samples and the serum-
ree samples, comprising 20 miRNAs, were identiﬁed. Fig. 3 visually
epicts the changes in miRNA expression due to growth changes
or the 12 miRNAs identiﬁed in all four analyses.
.4. Expression distance matrix indicates jointed expression of
ome clustered growth-correlating miRNAs
In order to determine whether the here identiﬁed overlap
etween all sample sets, consisting of 12 growth-correlating miR-
As, are located in miRNA clusters, genomically clustered miRNAs
f human, mouse and rat were retrieved from miRBase v21 based
n the 10 kb chromosomal distance criterion. Out of the 12 miR-
As, 8 were found to be clustered with other miRNAs, with 5 of
hem also found to be clustered in CHO (see Supplementary Table
). The expression levels of the miRNAs clustered together were
isually analyzed by the dendrogram created for all miRNAs based
pon their LogFC at different samples (see Supplementary Fig. 1).
iR-29b-3p, which is found twice in the genome, once clustered
o miR-29a-3p, and once to miR-29c-3p, shows very good expres-nology 235 (2016) 150–161
sion correlation to both of them. Both miR-29a-3p and miR-29c-3p
were also identiﬁed to be growth-correlating in all sample sets.
Also, miR-222-3p is in close proximity at the dendrogram to its
clustered miRNA, miR-221-3p. MiR-23a-3p only correlates to miR-
24-3p expression, but not to miR-27a-3p, and also miR-669a-3-3p
expression only correlates to part of the expressed miRNAs found
in close chromosomal proximity (miR-467c-3p, miR-669b-3p and
miR-669p-3p). While miR-300 does not show any correlation to its
genomically clustered miRNAs, miR-647 is the only member of its
cluster which is found expressed.
4. Discussion
4.1. Global miRNA expression and evaluation
So far, one study was conducted which reported miRNA lev-
els in CHO cells with different growth rates (Clarke et al., 2012),
focusing on interclonal changes where clones were derived from
the same host cell line. In order to gain a more comprehensive
overview about miRNA expression changes due to growth vari-
ation, different CHO cell lines, including adherent, suspension-
and serum-free adapted, l-Gln-free adapted host and recombinant
cells under varying cultivating conditions and in different batch
phases, were used for this study. The here performed analysis of
46 cross-species miRNA microarrays, a platform which was  pre-
viously successfully used and validated by qPCR in transcriptomic
experiments (Maccani et al., 2014; Hackl et al., 2014; Bort et al.,
2012) revealed 295 out of 2376 probes with a signal intensity above
our background criteria (see Supplementary Table 2). According to
miRBase v21 (Kozomara and Grifﬁths-Jones, 2014), 277 probe IDs
detecting distinct miRNAs are still valid. The number of expressed
miRNAs agrees with previously published miRNA proﬁling stud-
ies in CHO, ranging from 190 (Hammond et al., 2012) to 496 (Loh
et al., 2014) expressed miRNAs. More than 50% of these 277 probe
sequences did not match perfectly to already annotated CHO stem-
loops. The signals of those probes are most likely derived from
(a) unidentiﬁed stem-loops for CHO, (b) non-miRNA RNA species,
and (c) cross-hybridization. As the CHO (Hammond et al., 2011; Xu
et al., 2011) and C. griseus (Lewis et al., 2013; Brinkrolf et al., 2013)
genomes have been sequenced just recently, the assemblies are
still considered draft genomes (Jakobi et al., 2014), and it is prob-
able that not all miRNAs encoded in the CHO genome are present
in the current version of those draft genomes. Due to this, all 277
miRNAs were included for further analyses to not lose any miR-
NAs possibly present in CHO. Another possibility is that sequences
were falsely annotated as miRNAs, an issue that has been addressed
before (Berezikov et al., 2010), and is attracting more and more
attention (Kozomara and Grifﬁths-Jones, 2014; Wong and Wang,
2015). Cross-hybridization is a general technical issue of microar-
rays and could in future be prevented by using RNA-Seq.
4.2. Factors inﬂuencing global miRNA expression
As indicated by hierarchical clustering of sample IDs, the growth
phase is the factor with the most impact on global miRNA expres-
sion, as all but one sample in stationary or death phase cluster
isolated from all exponential samples (see Fig. 1B). The miRNA
expression of CHO cells is known to be dynamic during batch
cultures (Bort et al., 2012). Also, serum-free and suspension-
adaptation seems to have an inﬂuence on the miRNA expression,
as part of the FCS-supplied adherent cells cluster apart from sus-
pension and serum-free adapted cell lines. The change in miRNA
expression in CHO cells upon serum-free and suspension adapta-
tion has also been shown before (Hackl et al., 2011). The cell line
itself, the l-Gln-free adaptation, the cultivation method (shaken
G. Klanert et al. / Journal of Biotechnology 235 (2016) 150–161 155
Fig. 2. Growth-correlating miRNAs. (A) Number of positively (+) and negatively (−) growth-correlating miRNAs including either all samples (All), samples of the exponential




Probe ID Detected strand Growth Correlation All Samples—Correlation Coefﬁcient
Pearson Spearman
hsa-miR-222/mmu-miR-222/rno-miR-222 3p positive 0.752 0.800
hsa-miR-23a/mmu-miR-23a/rno-miR-23a 3p positive 0.518 0.679
hsa-miR-300 only one strand annotated positive 0.780 0.814
hsa-miR-3613-3p 3p positive 0.718 0.800
hsa-miR-4288 only one strand annotated positive 0.687 0.758
hsa-miR-4317 only one strand annotated positive 0.522 0.665
hsa-miR-647 only one strand annotated positive 0.772 0.791
mmu-miR-669a-3-3p 3p positive 0.694 0.696
mmu-miR-706 only one strand annotated positive 0.825 0.868
hsa-miR-29a/mmu-miR-29a/rno-miR-29a 3p negative −0.748 −0.762
hsa-miR-29b/mmu-miR-29b/rno-miR-29b 3p negative −0.734 −0.768
hsa-miR-29c/mmu-miR-29c/rno-miR-29c 3p negative −0.766 −0.789
156 G. Klanert et al. / Journal of Biotechnology 235 (2016) 150–161
Fig. 3. MiRNA expression versus growth rate. LogFC of each sample was  aligned to the growth rate for all constantly growth-correlating miRNAs. The line depicts the linear
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r in a fermenter) and miRNA engineering exhibit only a marginal
ffect on global miRNA expression in comparison to the above men-
ioned factors, as no distinct clustering pattern was  observed.
.3. Identiﬁcation of growth-correlating miRNAs and their
ssociation to miRNA clusters
High throughput screening (Fischer et al., 2015) and miRNA pro-
ling (Druz et al., 2011) (Lin et al., 2011; Bort et al., 2012; Clarke
t al., 2012; Hackl et al., 2014), applied to CHO cells eased the identi-
cation of miRNAs related to the growth phenotype. To expand the
epertoire of known growth-correlating miRNAs in CHO cells, we
orrelated the relative logarithmic expression values (derived from
elating the miRNA expression levels of each sample against the
RP) to the growth rates for either all 46 samples, or sample subsets
exponential, n = 36; serum-free, n = 38; serum-free + exponential,
 = 28). Most growth-correlating miRNAs were identiﬁed when
amples of the stationary and of death phase were included (see
ig. 2), which spanned the highest difference in growth rates (−0.34
o 1.18 d−1, see Fig. 1A). The majority of the here identiﬁed miR-
As correlated positively to the growth rate (see Fig. 2A), which
s consistent with earlier ﬁndings (Hackl et al., 2014; Clarke et al.,
012). An overlap of 12 growth-correlating miRNAs was  identiﬁed
etween all analyzed sample sets.
As miRNAs which are in close chromosomal proximity, often
how clustered (i.e. polycistronic) expression, we wanted to know
hether this phenomenon is also true for the 12 growth-correlating
iRNAs identiﬁed before. Chromosomal locations were addition-
lly derived from other species, as only limited information about
he genomic location of miRNAs is available for CHO. Of these
2 miRNAs, 8 are found in miRNA clusters, based on their inter-
hromosomal distance in the human, mouse and/or rat genomes,
ith miR-29b-3p deriving from two genomic locations. A subset
f those 8 miRNAs (n = 5) is also located in miRNA clusters in CHO
see Supplementary Table 4). Chromosomal instability of CHO cells
Worton et al., 1977; Lewis et al., 2013) and differences in post-
ranscriptional miRNA maturation regulation of clustered miRNAs
Ryazansky et al., 2011) could lead to non-correlating expression
atterns. Still, 4 of those 8 miRNAs present in clusters were found
o correlate to all other cluster members, and indicate polycistron-
cal expression in CHO (see Supplementary Fig. 1). The other four
iRNAs show either partly, or no correlation to their cluster mem-
ers.
.4. Function of positively growth-correlating miRNAs
Among the positively growth-correlating microRNAs, miR-23a
nd miR-222-3p are the most widely researched miRNAs. MiR-222-
p is in close chromosomal proximity to miR-221-3p, to which it
lso shows correlated expression levels (see Supplementary Table
 and Supplementary Fig. 1), and they belong to the same gene
amily. MiR-221-3p is found to be well correlated with growth rate
nly in the serum-free samples (see Supplementary Table 3). MiR-
22-3p is mostly recognized for the growth promoting ability in
umor cells and normal tissues, as it represses known cell cycle and
rowth inhibitors (Gillies and Lorimer, 2007), and also impairs apo-
tosis by targeting pro-apoptotic genes (Terasawa et al., 2009). This
oncomiR’ is considered as biomarker for prognostic and diagnostic
urposes, as it is found to be constantly upregulated in various types
f cancer (He et al., 2005; Wong et al., 2010). On the other hand, a
imited number of studies reported that miR-222-3p also possesses
ro-apoptotic and anti-proliferative features (Felli et al., 2005; Xiao
t al., 2011). The expression of the microRNA itself is induced by
rowth factors via the MAPK pathway (Terasawa et al., 2009), NF-
B and JUN (Galardi et al., 2011) and by oncogenes (Tsunoda et al.,
011).nology 235 (2016) 150–161 157
Mir-23a together with mir-23b make up the mir-23 gene fam-
ily. The 3p-strands of these two  miRNAs show a good expression
correlation between all samples (see Supplementary Fig. 1), but
miR-23b-3p is found correlated to the growth rate in only two data
sets (see Supplementary Table 3). Mir-23a is located in close chro-
mosomal proximity to two other miRNAs, mir-24-2 and mir-27a.
The expression levels of miR-24-3p and miR-23a-3p correlate well
between all samples (see Supplementary Fig. 1), and miR-24-3p
is also found to be correlating to the growth rate in one data set.
However, no good correlation is found between the expression lev-
els of miR-23a-3p and miR-27a-3p, which has been reported before
(Cao et al., 2012). The ‘oncomiR’ miR-23a has the ability to protect
cells from apoptosis by targeting pro-apoptotic genes (Ruan et al.,
2012). It is also able to induce epithelial- mesenchymal transition
(EMT) (Jahid et al., 2012), promote tumorigenesis (Tan et al., 2012)
and alleviate oxidative stress (Zhao et al., 2014) and is discussed
as biomarker, as it is found to be upregulated in different types of
cancer (Yong et al., 2013; Lee et al., 2011). In spite of its oncogenic
characteristics, miR-23a has also been reported to be downregu-
lated in certain types of cancer (Koller et al., 2013; He et al., 2014b),
as it can induce cellular senescence (Xishan et al., 2014), lower the
migration potential (Arabanian et al., 2014), impair growth (Wang
et al., 2014), and exhibit proapoptotic functions (Siegel et al., 2011).
The expression of the miRNA itself is directly induced by proto-
oncogenic CREB1 (Tan et al., 2012), and indirectly by STAT3 (Wang
et al., 2012), both of which are found upregulated in cancer. It is
also induced by HSP70 and CDK5 to prevent heat-shock induced
apoptosis (Roufayel et al., 2014).
Less is known about the other positively correlating miRNAs.
MiR-300, which does not show any correlation to its genomically
clustered miRNAs, is a member of the mir-154 gene family and is
able to repress EMT  in human tumor metastasis (Haga and Phinney,
2012), elevates the ability to repair DNA damages and to relieve
IR-induced G2 cell cycle arrest (He et al., 2014a). It is also found
to be higher expressed in cancer cells and in less differentiated
cells, upregulating their proliferation and downregulating differ-
entiation (He et al., 2014a), and, though no direct mRNA targets are
validated, it is predicted to target p53 (Bailey et al., 2010).
Likewise, miR-647, which is the only member of its miRNA clus-
ter found expressed here, has also been predicted to target p53
(Bailey et al., 2010), and Notch signaling (Zhao et al., 2013). In addi-
tion, it has been associated with drug-resistance in tumors (Kim
et al., 2014) and metastasis (Yang et al., 2013).
MiR-706 was  found to inhibit vesicular stomatitis virus-induced
apoptosis (Lian et al., 2010). In addition, it has also been shown that
miR-706 alters Stat1 levels (Wong et al., 2014).
Nothing is known about the function of miR-3613, miR-4288,
miR-4317 and miR-669a-3-3p, but miR-3613 and miR-4317 were
associated with cancer (Ji et al., 2014) (Sand et al., 2012) and miR-
669a-3-3p was found to correlate to some of its other miRNA cluster
members.
4.5. Function of negatively growth-correlating miRNAs
All 3 miRs, which correlate negatively to the growth rate, belong
to the mir-29 gene family. Mir-29b is located twice in the genome,
once in close proximity to mir-29a, and once next to mir-29c. All
3 share similar expression levels between all samples (see Sup-
plementary Fig. 1). The mir-29 gene family is mostly recognized
for its tumor suppressive function by executing anti-proliferative
(Fabbri et al., 2007), anti-migrational (Lang et al., 2010) and pro-
apoptotic functions (Park et al., 2009) in normal and tumor cells.
It is repressed in different types of cancer (Lang et al., 2010; Zhao
et al., 2010). The tumor-suppressive effect is exerted by directly
targeting anti-apoptotic (Xiong et al., 2010), cell cycle-promoting
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ddition, it is able to upregulate and activate p53, which is capable
f inducing apoptosis (Park et al., 2009). The miR-29 family is found
pregulated in quiescent cells (Bandyopadhyay et al., 2011), pro-
otes differentiation (Wang et al., 2008) and is capable of inducing
enescence in aged cells (Ugalde et al., 2011). But it is also found
pregulated in certain tumor cells (Hong et al., 2014), and can have
 positive effect on the migrational potential (Franceschetti et al.,
013). It controls global gene expression by targeting several genes
nvolved in DNA (de) methylation (Fabbri et al., 2007). The family
embers are associated with extracellular matrix (ECM) remodel-
ng, as they inhibit ECM gene expression (Maurer et al., 2010), target
enes involved in the extracellular matrix breakdown (Ramdas
t al., 2013), and negatively regulate EMT  (Rostas et al., 2014). They
re also involved in nutrient metabolism control, as the expression
s upregulated by nutrient limitation (Liang et al., 2013), and down-
egulated by high glucose levels (Du et al., 2010). The miR-29 family
tself is downregulated by oncogenes (Zhang et al., 2012).
.6. Phenotypes assigned with identiﬁed growth-correlating
iRNAs in CHO
Interestingly, none of the 12 miRNAs revealed by this study
as been identiﬁed by the only miRNA proﬁling study directly
elated to growth in CHO cells (Clarke et al., 2012), which was
ocusing on miRNA expression changes due to interclonal growth
ate variations. But miR-23a was found to be downregulated in
HO cells due to serum-free and suspension adaption, which is
ften accompanied with decreased growth (Hackl et al., 2011), and
n a tissue plasminogen activator (tPA)-producing cell line when
ompared to its host (Hammond et al., 2012). As miR-23a, the
xpression of miR-222 was also reduced in a recombinant cell
ine producing secreted alkaline phosphatase (Hammond et al.,
012). Its expression level is highest in the exponential growth
hase in CHO cells, with a reduced expression in later batch phases
Bort et al., 2012). The unexplored miR-4317 was  downregulated
n both recombinant cell lines mentioned above. These previous
eports conﬁrms our ﬁndings, as recombinant protein production
ften reduces the growth capacity. The miR-4288 was  found to be
igher expressed in high producer cells, which exhibited the same
rowth rate as low producer CHO cells due to steady state culti-
ation (Maccani et al., 2014), indicating an additional function for
his miRNA.
The proapoptotic function of miR-29a and miR-29c has been
onﬁrmed in CHO cells (Fischer et al., 2015), while the expression
f miR-29b (Bort et al., 2012) declined during later batch phases,
hich is contradictory to our results. The levels of miR-29b and
iR-29c are also lower in tPA-producing CHO cells (Hammond
t al., 2012), which could lead to higher stress capability.
. Conclusion
To this stage, studies that reported miRNA expression proﬁles
f CHO cells only included few cell lines and conditions or the
omparison of the same cell line under different conditions. We
ave here reported miRNA proﬁles from a comprehensive tran-
criptomic approach, which included a variety of CHO cell types
arvested under various growth conditions. Growth-correlating
iRNAs for the entire sample set as well as subsets (i.e. exponential,
erum-free, and exponential and serum-free CHO cells) revealed a
et of 12 miRNAs with robust correlation to growth in all sample
ets. This combination of 12 miRNAs includes known oncomiRs,
umor-suppressive miRNAs and seven less studied miRNAs. Eight
f the 12 identiﬁed miRNAs are considered to be present in genomic
iRNA cluster in human, mouse and rat, and ﬁve of those eight were
lso found in miRNA cluster in CHO, with four of them showing cor-nology 235 (2016) 150–161
relative expression to all other cluster members, indicating jointed
expression. The here identiﬁed growth rate correlating miRNAs
represent rational CHO cell line engineering targets, and thus will
be further tested to evaluate their potential to regulate growth rate.
In addition, they are valuable biomarkers for clone selection and
bioprocess/media optimization to enhance growth performance.
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